University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Items where Author is "Falk, S"

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 3.

Article

Lee, SM, Khan, I, Upadhyay, S, Lewanski, C, Falk, S, Skailes, G, Marshall, E, Woll, PJ, Hatton, M, Lal, R, Jones, R, Toy, E, Chao, D, Middleton, G, Bulley, S, Ngai, Y, Rudd, R, Hackshaw, A and Boshoff, C (2012) First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial LANCET ONCOLOGY, 13 (11). pp. 1161-1170.

Cunningham, D, Falk, S and Jackson, DL (2002) Clinical and economic benefits of irinotecan in combination with 5-fluorouracil and folinic acid as first line treatment of metastatic colorectal cancer British Journal of Cancer, 86 (11). pp. 1677-1683.

Cunningham, D, Falk, S and Jackson, DL (2000) Irinotecan and infusional 5-fluorouracil as first line treatment of metastatic colorectal cancer: improved survival and cost-effective compared with infusional 5-FU Proc Am Soc Clin Oncol, 19. 981A-981A.

This list was generated on Sat Sep 23 20:12:31 2017 UTC.

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800